Optical Genome Mapping in Hematological Malignancies (CARTOGEN)

Regional University Hospital Center (CHRU)

Status: Enrolling

Conditions: MDS; Other Hematologic Malignant Neoplasms; ALL

Study type: Observational

Funder types: Other

Identifiers

NCT05009537

CARTOGEN - 29BRC21.0211

Details and patient eligibility

About

Establish the diagnostic potential of optical genome mapping in patients with suspected hematologic cancer

Enrollment: 200 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Minor/Major Patients
• Patients with suspected hemopathies for whom we receive a sample for diagnosis in the chromosomal genetics laboratory or for whom a diagnosis of hemopathy has already been made.
• No objection made or consent given

Exclusion criteria

• Patients under judicial protection (guardianship, curatorship, ...),
• Refusal to participate